These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 8787542
21. The effect of heparin on Cu(2+)-mediated oxidation of human low-density lipoproteins. Albertini R, Rindi S, Passi A, Palladini G, Pallavicini G, De Luca G. FEBS Lett; 1995 Dec 18; 377(2):240-2. PubMed ID: 8543059 [Abstract] [Full Text] [Related]
24. Novel 3,5-diaryl pyrazolines and pyrazole as low-density lipoprotein (LDL) oxidation inhibitor. Jeong TS, Kim KS, Kim JR, Cho KH, Lee S, Lee WS. Bioorg Med Chem Lett; 2004 Jun 07; 14(11):2719-23. PubMed ID: 15125921 [Abstract] [Full Text] [Related]
28. The dose-dependent effect of copper-chelating agents on the kinetics of peroxidation of low-density lipoprotein (LDL). Pinchuk I, Gal S, Lichtenberg D. Free Radic Res; 2001 Apr 07; 34(4):349-62. PubMed ID: 11328672 [Abstract] [Full Text] [Related]
29. Early destruction of tryptophan residues of apolipoprotein B is a vitamin E-independent process during copper-mediated oxidation of LDL. Giessauf A, Steiner E, Esterbauer H. Biochim Biophys Acta; 1995 May 17; 1256(2):221-32. PubMed ID: 7766701 [Abstract] [Full Text] [Related]
34. The pyridoindole antioxidant stobadine inhibited glycation-induced absorbance and fluorescence changes in albumin. Stefek M, Drozdikova I, Vajdova K. Acta Diabetol; 1996 Mar 17; 33(1):35-40. PubMed ID: 8777283 [Abstract] [Full Text] [Related]
36. Antioxidative effect of schisanhenol on human low density lipoprotein and its quantum chemical calculation. Yu LH, Liu GT, Sun YM, Zhang HY. Acta Pharmacol Sin; 2004 Aug 17; 25(8):1038-44. PubMed ID: 15301737 [Abstract] [Full Text] [Related]